A triple-blind, randomized clinical trial will be conducted on newborns. In the first stage, participants will be selected via purposive sampling from among those who meet the study's inclusion criteria and for whom parents have provided written informed consent. Participants will then be randomly assigned to either an intervention group or a control group using a balanced block randomization method (with a block size of four). Randomization will be performed prior to the commencement of participant recruitment; codes—designated as 'A' (intervention group) and 'B' (control group)—will be established, and their sequence determined. Specifically, the following four-item combinations will be generated: AABB, ABAB, ABBA, BABA, BBAA, and BAAB. A six-sided die (numbered 1 through 6) will then be used to randomly select these combinations, thereby establishing the allocation sequence (the allocation list) for assigning individuals to the intervention and control groups. The allocation list will be kept confidential by the physician (principal investigator). It should be noted that randomization will be performed separately for each hospital (Shahid Rahimi and Shahid Madani).
Once an individual is determined by the physician (principal investigator) to be eligible for the study, they will be assigned to the appropriate group based on the allocation list. To ensure that neither the parents nor the assessor are aware of the group assignment, each study participant will be assigned a random, non-sequential four-digit number, which will be recorded in the allocation list. The physician will document this four-digit number in the participant's medical record. The team’s statistician, who is responsible for data analysis, will have no direct contact with the participants and will not be involved in data collection.
In this study, a triple-blind design is employed (involving parents/participants, the outcome assessor, and the statistical analyst). Regarding the implementation procedure: the randomization sequence (allocation list) is generated prior to the start of the study, separately for each of the two hospitals (Shahid Rahimi and Shahid Madani). This list is kept confidential by a department supervisor—who has no involvement in recruitment, intervention, assessment, or analysis—and remains inaccessible to the recruiting physician and the assessor. Once an infant is deemed eligible by the physician (supervising faculty member) and parental consent is obtained, the infant is assigned to a group based on the next entry in the allocation list. Consequently, the physician remains unaware of the upcoming group assignment prior to determining eligibility, thereby preventing selective enrollment (allocation concealment). To ensure parental blinding, parents are not informed of their infant’s group assignment. To blind the outcome assessor, each participant is assigned a random, non-sequential four-digit code, which is recorded in the allocation list; the physician enters only this code into the patient’s medical record. Thus, when evaluating outcomes, the assessor encounters only the code, from which the intervention or control group cannot be identified. Both the intervention (inhaled salbutamol) and the control (distilled water) are prepared in identical, unlabeled vials—appearing as clear, colorless solutions—and the method of administration (nebulizer), the device used, and the duration and conditions of the procedure are identical for both groups. The preparation and delivery of the solution, based on the allocation list, are carried out by an independent nurse who is not involved in the assessment of outcomes. The outcome assessor is not present at the bedside during the intervention; instead, they assess the outcomes only after the intervention is complete, using the participant’s four-digit code. Consequently, the assessor cannot determine the participant's assigned group based on the appearance or odor of the medication, nor through the method of administration.
Similarly, the statistician responsible for data analysis has no direct contact with the participants and is not involved in data collection. The analysis is performed using the four-digit codes, and the allocation list is not made available to the statistician until the final analysis is complete. In the event of a serious adverse event that necessitates knowledge of the participant's group assignment, the blinding is broken only for that specific individual, subject to approval by the department head.
بهینهسازی با ChatGPT